Organism name | Senecio chionophilus |
---|---|
Genus | Senecio |
Family | Asteraceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Senecio |
---|---|
Linked NCBI taxonomy ID | 18794 |
Linked level | genus |
Family in NCBI taxonomy | Asteraceae |
---|---|
ID | 4210 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | asterids |
---|---|
ID | 71274 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00045098
![]() |
Taraxasterone
/ (+)-Taraxasterone |
![]() |
||||||
C00044566
![]() |
beta-Amyrenone
|
CHEMBL461060
|
No. 13 | No. 51 |
![]() |
|||
C00003737
![]() |
alpha-Amyrin
/ alpha-Amyrine / alpha-Amyrenol |
No. 23 | No. 51 |
![]() |
||||
C00003738
![]() |
beta-Amyrin
/ beta-Amirin / beta-Amyrine / beta-Amyrenol |
C036380
|
0 / 4 | No. 23 | No. 51 |
![]() |
||
C00003749
![]() |
Lupeol
/ Lupenol / (+)-Lupenol |
CHEMBL289191
CHEMBL459702 |
C010480
|
3 / 0 / 0 | 2 / 6 | No. 23 | No. 51 |
![]() |
C00019220
![]() |
Lupenone
|
CHEMBL486393
CHEMBL575188 |
3 / 4 / 2 | No. 23 | No. 51 |
![]() |
||
C00003757
![]() |
Taraxasterol
|
CHEMBL497525
|
C079988
|
No. 23 | No. 51 |
![]() |
||
C00003672
![]() |
Sitosterol
/ beta-sitosterl / (-)-beta-Sitosterol / Stigmast-5-en-3beta-ol |
CHEMBL221542
CHEMBL1398443 CHEMBL1875388 |
17 / 19 / 12 | No. 53 | No. 11 |
![]() |
||
C00012483
![]() |
Betula pubescens
/ Caryophyllene oxide / trans-Caryophyllene oxide / beta-Caryophyllene epoxide / (-)-Epoxydihydrocaryophyllene / 6,7-Epoxy-3(15)-caryophyllene / (-)-beta-Caryophyllene epoxide / 4beta,5alpha-Epoxycaryophyllene / Caryophyllene 4beta,5alpha-epoxide |
CHEMBL399036
CHEMBL508894 CHEMBL479134 CHEMBL1513806 CHEMBL1553274 |
3 / 1 / 3 | No. 500 |
![]() |
|||
C00019308
![]() |
Doursterol
/ Daucosterin / 3-O-beta-D-Glucopyranosyl sitosterol / beta-Sitosterol 3-O-beta-D-glucopyranoside |
CHEMBL197711
CHEMBL506678 CHEMBL2304043 |
C011015
|
5 / 4 / 2 | 0 / 3 | No. 520 |
![]() |
|
C00017413
![]() |
6beta-Angeloyloxy-10alphaH-9-oxofuranoeremophilane
|
No. 645 |
![]() |
|||||
C00002698
![]() |
Piceol
/ p-Hydroxyacetophenone / 4'-Hydroxyacetophenone |
CHEMBL201083
|
C031335
|
5 / 3 / 3 | No. 2849 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P08047 | Transcription factor Sp1 | Unclassified protein | C00003672 C00003749 C00019308 | 0 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00003672 C00012483 | 1 / 1 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00003672 C00012483 | 0 / 1 |
P06746 | DNA polymerase beta | Enzyme | C00003672 C00019308 | 0 / 0 |
P18031 | Tyrosine-protein phosphatase non-receptor type 1 | Tyr | C00003672 C00019308 | 0 / 0 |
P49841 | Glycogen synthase kinase-3 beta | Gsk | C00003672 C00019308 | 0 / 0 |
P14679 | Tyrosinase | Oxidoreductase | C00003672 C00019220 | 4 / 2 |
P00734 | Prothrombin | S1A | C00003672 C00019308 | 4 / 2 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00003672 C00012483 | 0 / 1 |
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00003672 | 1 / 0 |
P11387 | DNA topoisomerase 1 | Isomerase | C00003749 | 0 / 0 |
P11388 | DNA topoisomerase 2-alpha | Isomerase | C00003749 | 0 / 0 |
O60656 | UDP-glucuronosyltransferase 1-9 | Enzyme | C00002698 | 0 / 0 |
P08183 | Multidrug resistance protein 1 | drug | C00003672 | 1 / 0 |
P51649 | Succinate-semialdehyde dehydrogenase, mitochondrial | Oxidoreductase | C00002698 | 1 / 1 |
P16473 | Thyrotropin receptor | Glycohormone receptor | C00003672 | 3 / 2 |
P80404 | 4-aminobutyrate aminotransferase, mitochondrial | Transferase | C00002698 | 1 / 1 |
Q96RI1 | Bile acid receptor | NR1H4 | C00019220 | 0 / 0 |
P37058 | Testosterone 17-beta-dehydrogenase 3 | Enzyme | C00002698 | 1 / 1 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00003672 | 0 / 0 |
P03372 | Estrogen receptor | NR3A1 | C00003672 | 1 / 1 |
Q8TDU6 | G-protein coupled bile acid receptor 1 | Steroid-like ligand receptor | C00019220 | 0 / 0 |
P49798 | Regulator of G-protein signaling 4 | Unclassified protein | C00003672 | 2 / 0 |
P19224 | UDP-glucuronosyltransferase 1-6 | Enzyme | C00002698 | 0 / 0 |
P80365 | Corticosteroid 11-beta-dehydrogenase isozyme 2 | Enzyme | C00003672 | 1 / 1 |
Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00003672 | 1 / 1 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
1499 | CTNNB1, CTNNB, MRD19, armadillo | catenin (cadherin-associated protein), beta 1, 88kDa |
C00003749
|
5728 | PTEN, 10q23del, BZS, CWS1, DEC, GLM2, MHAM, MMAC1, PTEN1, TEP1 | phosphatase and tensin homolog (EC:3.1.3.67 3.1.3.16 3.1.3.48) |
C00003749
|
OMIM | preferred title | UniProt |
---|---|---|
#264300 | 17-beta hydroxysteroid dehydrogenase iii deficiency |
P37058
|
#103470 | Albinism, ocular, with sensorineural deafness |
P14679
|
#203100 | Albinism, oculocutaneous, type ia; oca1a |
P14679
|
#606952 | Albinism, oculocutaneous, type ib; oca1b |
P14679
|
#218030 | Apparent mineralocorticoid excess; ame |
P80365
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#615363 | Estrogen resistance; estrr |
P03372
|
#613163 | Gaba-transaminase deficiency |
P80404
|
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
#614390 | Pregnancy loss, recurrent, susceptibility to, 2; rprgl2 |
P00734
|
#613679 | Prothrombin deficiency, congenital |
P00734
|
#604906 | Schizophrenia 9; sczd9 |
P49798
|
#181500 | Schizophrenia; sczd |
P49798
|
#601800 | Skin/hair/eye pigmentation, variation in, 3; shep3 |
P14679
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#601367 | Stroke, ischemic |
P00734
|
#271980 | Succinic semialdehyde dehydrogenase deficiency; ssadhd |
P51649
|
#188050 | Thrombophilia due to thrombin defect; thph1 |
P00734
|
KEGG | name | UniProt |
---|---|---|
H00223 | Inherited thrombophilia |
P00734
(related)
|
H01254 | Congenital prothrombin deficiency |
P00734
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
|
H00036 | Osteosarcoma |
P08684
(marker)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00168 | Oculocutaneous albinism (OCA) |
P14679
(related)
|
H00038 | Malignant melanoma |
P14679
(marker)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) |
P37058
(related)
|
H00835 | Succinic semialdehyde dehydrogenase (SSADH) deficiency |
P51649
(related)
|
H00259 | Apparent mineralocorticoid excess syndrome |
P80365
(related)
|
H01257 | GABA-transaminase deficiency |
P80404
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q9NUW8
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D006528 | Carcinoma, Hepatocellular |
C00003749
|
D009202 | Cardiomyopathies |
C00003749
|
D006937 | Hypercholesterolemia |
C00003749
|
D009374 | Neoplasms, Experimental |
C00003749
|
D012878 | Skin Neoplasms |
C00003749
|
D014947 | Wounds and Injuries |
C00003749
|
D002493 | Central Nervous System Diseases |
C00019308
|
D003072 | Cognition Disorders |
C00019308
|
D013118 | Spinal Cord Diseases |
C00019308
|
D005157 | Facial Pain |
C00003738
|
D006930 | Hyperalgesia |
C00003738
|
D007249 | Inflammation |
C00003738
|
D010146 | Pain |
C00003738
|